L-Carnitine Solution For Injection 200Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

L-Carnitine: Solution for injection (200mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LEVOCARNITINE (lee voe KAR ni teen) is a nutritional supplement. It used to treat people who do not have enough carnitine in their body.

This supplemnet may be used for other purposes; ask your health care provider or pharmacist if you have questions.

In-Depth Information
Select a Medication

Levocarnitine 200mg/ml Solution for Injection (NOVAPLUS)

NDC: 553900436
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Renal Impairment, Carnitine Deficiency

Sometimes used for but not FDA approved for the following conditions:
Acute Myocardial Infarction, Type 2 Diabetes Mellitus, Cardiomyopathy, Infertility

Storage Information
Protect from light
Store in original container
Store at controlled room temperature (between 68 and 77 degrees F)
Levocarnitine 200mg/ml Solution for Injection (NOVAPLUS)

Reported Side Effects for Levocarnitine 200mg/ml Solution for Injection (NOVAPLUS)

Nervousness Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Excessive Mucle Tone Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
2.0-3.0%*
Severity: MILD
Onset: DELAYED
Irregular Heart Beat Incidence:
2.0-6.0%*
Severity: SEVERE
Onset: EARLY
Sinus Infection Incidence:
2.0-3.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
2.0-6.0%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
2.0-9.0%*
Severity: MODERATE
Onset: EARLY
Melena Incidence:
2.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
2.0-9.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
3.0-8.0%*
Severity: MILD
Onset: RAPID
Increased Blood Volume Incidence:
3.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
3.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
3.0-8.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
3.0-12.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
3.0-8.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
3.0-6.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
3.0-19.0%*
Severity: MODERATE
Onset: RAPID
Lazy Eye Incidence:
3.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
3.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
3.0-6.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
3.0-37.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
3.0-11.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
5.0-12.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
5.0-9.0%*
Severity: MODERATE
Onset: RAPID
Depression Incidence:
5.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
5.0-9.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
5.0-12.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
5.0-21.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
6.0-15.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
6.0-9.0%*
Severity: MILD
Onset: DELAYED
High Calcium Levels Incidence:
6.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Rhinitis Incidence:
6.0-11.0%*
Severity: MILD
Onset: EARLY
High Potassium Level Incidence:
6.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
8.0-12.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
9.0-35.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
9.0-21.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
9.0-18.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
10.0-18.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
10.0-24.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
15.0-27.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
18.0-21.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
27.0-38.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with L-Carnitine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5